Suppr超能文献

配体如何揭示G蛋白偶联受体的分子药理学。

How Ligands Illuminate GPCR Molecular Pharmacology.

作者信息

Wacker Daniel, Stevens Raymond C, Roth Bryan L

机构信息

Department of Pharmacology and Division of Chemical Biology and Medicinal Chemistry, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27514, USA.

Departments of Biological Sciences and Chemistry, Bridge Institute, University of Southern California, Los Angeles, CA 90089, USA.

出版信息

Cell. 2017 Jul 27;170(3):414-427. doi: 10.1016/j.cell.2017.07.009.

Abstract

G protein-coupled receptors (GPCRs), which are modulated by a variety of endogenous and synthetic ligands, represent the largest family of druggable targets in the human genome. Recent structural and molecular studies have both transformed and expanded classical concepts of receptor pharmacology and have begun to illuminate the distinct mechanisms by which structurally, chemically, and functionally diverse ligands modulate GPCR function. These molecular insights into ligand engagement and action have enabled new computational methods and accelerated the discovery of novel ligands and tool compounds, especially for understudied and orphan GPCRs. These advances promise to streamline the development of GPCR-targeted medications.

摘要

G蛋白偶联受体(GPCRs)可被多种内源性和合成配体调节,是人类基因组中最大的可成药靶点家族。最近的结构和分子研究既改变又扩展了受体药理学的经典概念,并开始阐明结构、化学和功能各异的配体调节GPCR功能的不同机制。这些对配体结合和作用的分子见解催生了新的计算方法,并加速了新型配体和工具化合物的发现,尤其是针对研究不足的孤儿GPCR。这些进展有望简化GPCR靶向药物的开发。

相似文献

2
Emerging structural insights into biased GPCR signaling.新兴的偏向性 G 蛋白偶联受体信号转导结构见解。
Trends Biochem Sci. 2014 Dec;39(12):594-602. doi: 10.1016/j.tibs.2014.10.001. Epub 2014 Nov 4.
3
Discovery of new GPCR ligands to illuminate new biology.发现新的G蛋白偶联受体配体以揭示新生物学。
Nat Chem Biol. 2017 Nov;13(11):1143-1151. doi: 10.1038/nchembio.2490. Epub 2017 Oct 18.
4
Bridging the gap: bitopic ligands of G-protein-coupled receptors.弥合差距:G 蛋白偶联受体的双配体。
Trends Pharmacol Sci. 2013 Jan;34(1):59-66. doi: 10.1016/j.tips.2012.10.003. Epub 2012 Nov 20.

引用本文的文献

4
Genetics-Based Targeting Strategies for Precise Neuromodulation.基于遗传学的精确神经调节靶向策略。
Adv Sci (Weinh). 2025 Jul;12(28):e13817. doi: 10.1002/advs.202413817. Epub 2025 May 19.
7
Discovering Key Activation Hotspots in the M Muscarinic Receptor.发现M型毒蕈碱受体中的关键激活热点
J Am Chem Soc. 2025 Apr 9;147(14):11754-11765. doi: 10.1021/jacs.4c14385. Epub 2025 Mar 14.

本文引用的文献

7
Trial watch: Opportunities and challenges of the 2016 target landscape.试验观察:2016年目标格局的机遇与挑战。
Nat Rev Drug Discov. 2017 Jan;16(1):10-11. doi: 10.1038/nrd.2016.263. Epub 2016 Dec 16.
8
Intracellular allosteric antagonism of the CCR9 receptor.CCR9 受体的细胞内变构拮抗作用。
Nature. 2016 Dec 15;540(7633):462-465. doi: 10.1038/nature20606. Epub 2016 Dec 7.
10
Crystal Structure of the Human Cannabinoid Receptor CB.人类大麻素受体CB的晶体结构
Cell. 2016 Oct 20;167(3):750-762.e14. doi: 10.1016/j.cell.2016.10.004.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验